Report: If this research holds up, it’s incredibly good thing for the rest worldwide.
According to a new study, the Pfizer-BioNTech vaccine was almost 90 percent effective in preventing COVID-19 transmission in Israel – an early data point showing that vaccines are at least largely effective in stopping the spread of the coronavirus.
Bloomberg reported that the vaccine was 89.4 percent effective in preventing laboratory-confirmed COVID infections. The results also demonstrate the effectiveness of the vaccine in preventing both symptomatic and asymptomatic carriers from transmitting the disease.
This is not all.
During the study period, the deadly B.1.1.7 variant from the UK was the predominant species in Israel, accounting for over 81 percent of positive COVID tests in the country, The Financial Times reported. This seems to suggest that the Pfizer-BioNTech vaccine is also highly effective against this strain.
However, it is important to remember that the results have yet to be reviewed by the referee. Therefore, although the data was backed by a person familiar with the study and reported by various publications, this should still be taken with a grain of salt until more experts review and discuss the data.
This news comes right after Israel’s massive vaccination program launched on December 20th. Since then, Israeli authorities have reportedly vaccinated almost half of its population with at least one dose.
If the reports are correct, this would be a major turning point in the coronavirus outbreak, demonstrating the effectiveness of mass vaccination efforts coordinated by world governments.
Prizer-Biontech shot stops Covid-19’s spread, israel study shows (Bloomberg)
More about Covid-19: Johns Hopkins Professor: Us will hit covid herd immunity by april
More about Covid-19: Prizer says its covid vaccine is 93% effective after just one shot